Clinical aspect, pathogenesis and therapy options of alopecia induced by hormonal therapy for breast cancer
Adjuvant hormonal therapy is one of the most important treatments of hormone-receptor-positive breast cancer and includes selective estrogen receptor modulators, aromatase inhibitors, and luteinizing hormone-releasing hormone analogs. In patients receiving these drugs, a progressive recession of fro...
Guardado en:
Autores principales: | , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Open Exploration Publishing Inc.
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/f128ca6dd8064316846e96e04b306f01 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:f128ca6dd8064316846e96e04b306f01 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:f128ca6dd8064316846e96e04b306f012021-11-08T10:10:44ZClinical aspect, pathogenesis and therapy options of alopecia induced by hormonal therapy for breast cancer10.37349/etat.2021.000592692-3114https://doaj.org/article/f128ca6dd8064316846e96e04b306f012021-10-01T00:00:00Zhttps://www.explorationpub.com/Journals/etat/Article/100259https://doaj.org/toc/2692-3114Adjuvant hormonal therapy is one of the most important treatments of hormone-receptor-positive breast cancer and includes selective estrogen receptor modulators, aromatase inhibitors, and luteinizing hormone-releasing hormone analogs. In patients receiving these drugs, a progressive recession of frontal-temporal hairlines is often observed, such as a certain grade of hair miniaturization in the same areas and the central scalp area, producing a pseudo-female androgenic alopecia, which has to be considered oncotherapy-induced alopecia. The aim of this work, is to describe the clinical aspects and pathogenesis of this type of alopecia and to analyze the different drugs which have been proposed until now. The authors concude that topical hormones should not be considered as a therapeutic approach because of their direct or indirect oncogenic potential. A therapeutic approach that could be both safe and effective is proposed.Alfredo RossiGemma CaroFrancesca MagriMaria Caterina FortunaMarta CarlesimoOpen Exploration Publishing Inc.articlealopeciahormonal therapybreast cancerInternal medicineRC31-1245ENExploration of Targeted Anti-tumor Therapy, Vol 2, Iss 5, Pp 490-495 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
alopecia hormonal therapy breast cancer Internal medicine RC31-1245 |
spellingShingle |
alopecia hormonal therapy breast cancer Internal medicine RC31-1245 Alfredo Rossi Gemma Caro Francesca Magri Maria Caterina Fortuna Marta Carlesimo Clinical aspect, pathogenesis and therapy options of alopecia induced by hormonal therapy for breast cancer |
description |
Adjuvant hormonal therapy is one of the most important treatments of hormone-receptor-positive breast cancer and includes selective estrogen receptor modulators, aromatase inhibitors, and luteinizing hormone-releasing hormone analogs. In patients receiving these drugs, a progressive recession of frontal-temporal hairlines is often observed, such as a certain grade of hair miniaturization in the same areas and the central scalp area, producing a pseudo-female androgenic alopecia, which has to be considered oncotherapy-induced alopecia. The aim of this work, is to describe the clinical aspects and pathogenesis of this type of alopecia and to analyze the different drugs which have been proposed until now. The authors concude that topical hormones should not be considered as a therapeutic approach because of their direct or indirect oncogenic potential. A therapeutic approach that could be both safe and effective is proposed. |
format |
article |
author |
Alfredo Rossi Gemma Caro Francesca Magri Maria Caterina Fortuna Marta Carlesimo |
author_facet |
Alfredo Rossi Gemma Caro Francesca Magri Maria Caterina Fortuna Marta Carlesimo |
author_sort |
Alfredo Rossi |
title |
Clinical aspect, pathogenesis and therapy options of alopecia induced by hormonal therapy for breast cancer |
title_short |
Clinical aspect, pathogenesis and therapy options of alopecia induced by hormonal therapy for breast cancer |
title_full |
Clinical aspect, pathogenesis and therapy options of alopecia induced by hormonal therapy for breast cancer |
title_fullStr |
Clinical aspect, pathogenesis and therapy options of alopecia induced by hormonal therapy for breast cancer |
title_full_unstemmed |
Clinical aspect, pathogenesis and therapy options of alopecia induced by hormonal therapy for breast cancer |
title_sort |
clinical aspect, pathogenesis and therapy options of alopecia induced by hormonal therapy for breast cancer |
publisher |
Open Exploration Publishing Inc. |
publishDate |
2021 |
url |
https://doaj.org/article/f128ca6dd8064316846e96e04b306f01 |
work_keys_str_mv |
AT alfredorossi clinicalaspectpathogenesisandtherapyoptionsofalopeciainducedbyhormonaltherapyforbreastcancer AT gemmacaro clinicalaspectpathogenesisandtherapyoptionsofalopeciainducedbyhormonaltherapyforbreastcancer AT francescamagri clinicalaspectpathogenesisandtherapyoptionsofalopeciainducedbyhormonaltherapyforbreastcancer AT mariacaterinafortuna clinicalaspectpathogenesisandtherapyoptionsofalopeciainducedbyhormonaltherapyforbreastcancer AT martacarlesimo clinicalaspectpathogenesisandtherapyoptionsofalopeciainducedbyhormonaltherapyforbreastcancer |
_version_ |
1718442770274713600 |